Thymidylate synthase inhibitor: Began a Phase Ib trial

Agouron Pharmaceuticals Inc. (AGPH) La Jolla, Calif. Product: AG-337, thymidylate synthase inhibitor Indication: Treat cancer Status: Began a Phase Ib trial to confirm the dose and schedule of admini...